PMID- 30127847 OWN - NLM STAT- PubMed-not-MEDLINE LR - 20230928 IS - 1754-1611 (Print) IS - 1754-1611 (Electronic) IS - 1754-1611 (Linking) VI - 12 DP - 2018 TI - A facile in vitro platform to study cancer cell dormancy under hypoxic microenvironments using CoCl(2). PG - 12 LID - 10.1186/s13036-018-0106-7 [doi] LID - 12 AB - BACKGROUND: While hypoxia has been well-studied in various tumor microenvironments, its role in cancer cell dormancy is poorly understood, in part due to a lack of well-established in vitro and in vivo models. Hypoxic conditions under conventional hypoxia chambers are relatively unstable and cannot be maintained during characterization outside the chamber since normoxic response is quickly established. To address this challenge, we report a robust in vitro cancer dormancy model under a hypoxia-mimicking microenvironment using cobalt chloride (CoCl(2)), a hypoxia-mimetic agent, which stabilizes hypoxia inducible factor 1-alpha (HIF1alpha), a major regulator of hypoxia signaling. METHODS: We compared cellular responses to CoCl(2) and true hypoxia (0.1% O(2)) in different breast cancer cell lines (MCF-7 and MDA-MB-231) to investigate whether hypoxic regulation of breast cancer dormancy could be mimicked by CoCl(2). To this end, expression levels of hypoxia markers HIF1alpha and GLUT1 and proliferation marker Ki67, cell growth, cell cycle distribution, and protein and gene expression were evaluated under both CoCl(2) and true hypoxia. To further validate our platform, the ovarian cancer cell line OVCAR-3 was also tested. RESULTS: Our results demonstrate that CoCl(2) can mimic hypoxic regulation of cancer dormancy in MCF-7 and MDA-MB-231 breast cancer cell lines, recapitulating the differential responses of these cell lines to true hypoxia in 2D and 3D. Moreover, distinct gene expression profiles in MCF-7 and MDA-MB-231 cells under CoCl(2) treatment suggest that key cell cycle components are differentially regulated by the same hypoxic stress. In addition, the induction of dormancy in MCF-7 cells under CoCl(2) treatment is HIF1alpha-dependent, as evidenced by the inability of HIF1alpha-suppressed MCF-7 cells to exhibit dormant behavior upon CoCl(2) treatment. Furthermore, CoCl(2) also induces and stably maintains dormancy in OVCAR-3 ovarian cancer cells. CONCLUSIONS: These results demonstrate that this CoCl(2)-based model could provide a widely applicable in vitro platform for understanding induction of cancer cell dormancy under hypoxic stress. FAU - Lee, Hak Rae AU - Lee HR AD - Department of Chemical Engineering and Materials Science, University of Minnesota, Minneapolis, MN 55455 USA. ISNI: 0000000419368657. GRID: grid.17635.36 FAU - Leslie, Faith AU - Leslie F AD - Department of Chemical Engineering and Materials Science, University of Minnesota, Minneapolis, MN 55455 USA. ISNI: 0000000419368657. GRID: grid.17635.36 FAU - Azarin, Samira M AU - Azarin SM AUID- ORCID: 0000-0003-0395-4988 AD - Department of Chemical Engineering and Materials Science, University of Minnesota, Minneapolis, MN 55455 USA. ISNI: 0000000419368657. GRID: grid.17635.36 LA - eng GR - P30 CA077598/CA/NCI NIH HHS/United States PT - Journal Article DEP - 20180803 PL - England TA - J Biol Eng JT - Journal of biological engineering JID - 101306640 PMC - PMC6091074 OTO - NOTNLM OT - Cancer dormancy OT - Cobalt chloride OT - Hypoxia OT - In vitro model OT - Tumor microenvironment OT - Tumor recurrence COIS- Not applicable. Not applicable. The authors declare that they have no competing interests. Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations. EDAT- 2018/08/22 06:00 MHDA- 2018/08/22 06:01 PMCR- 2018/08/03 CRDT- 2018/08/22 06:00 PHST- 2018/03/01 00:00 [received] PHST- 2018/06/26 00:00 [accepted] PHST- 2018/08/22 06:00 [entrez] PHST- 2018/08/22 06:00 [pubmed] PHST- 2018/08/22 06:01 [medline] PHST- 2018/08/03 00:00 [pmc-release] AID - 106 [pii] AID - 10.1186/s13036-018-0106-7 [doi] PST - epublish SO - J Biol Eng. 2018 Aug 3;12:12. doi: 10.1186/s13036-018-0106-7. eCollection 2018.